1
|
Sastre LR, Stroud B, Smith E, Hendrix K, McBride O. Development and Evaluation of the Delivery-Based HEALED Produce Rx Program for Uninsured Patients With Diabetes in Rural Eastern North Carolina. Prev Chronic Dis 2023; 20:E51. [PMID: 37347780 DOI: 10.5888/pcd20.220384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/24/2023] Open
Abstract
Produce prescription (PRx) programs have emerged as a preventive treatment to subsidize the cost of fruits and vegetables for people with lower income and have shown promise in improving diet quality and diabetes-related health outcomes (eg, glycated hemoglobin A1c). Researchers from the Department of Nutrition Science at East Carolina University worked with the Wayne Action Teams for Community Health (WATCH) Clinic, a safety-net clinic in rural Eastern North Carolina, and a local research farm to develop a PRx program for rural patients with type 2 diabetes and no health insurance. Preliminary patient surveys identified high levels of interest in a PRx program and a desire for recipes to accompany the produce. Formative evaluation results via telephone interviews with eligible patients identified transportation barriers to participation and the desire for complementary nutrition education and culinary resources. These results led to a delivery-based PRx program implemented from June through November 2021. Patients received weekly home delivery of an average of 4.7 pounds of fruits and vegetables and complementary nutrition and health education materials and culinary resources (cookbook, recipes). The level of patient satisfaction with the program was high; the reported level of consumption of produce, including unfamiliar produce, was high; educational resources were associated with increased knowledge and motivation to make healthful lifestyle changes, and glycemic control significantly improved. Ensuring that patients have a voice in the design and implementation of PRx programs is crucial to success. Ongoing use of rigorous formative and process evaluations can ensure appropriateness, use, and a positive effect of PRx programs, and they are needed to establish best practices for implementation.
Collapse
Affiliation(s)
- Lauren R Sastre
- Department of Nutrition Science, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina
- Department of Nutrition Science, East Carolina University, Health Sciences Building, Ste 2435 F, Greenville NC 27834
| | - Brandon Stroud
- Department of Nutrition Science, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina
| | - Elisa Smith
- Department of Nutrition Science, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina
| | - Khadijah Hendrix
- Department of Nutrition Science, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina
| | - Olivia McBride
- Department of Nutrition Science, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina
| |
Collapse
|
2
|
Gwilym BL, Pallmann P, Waldron CA, Thomas-Jones E, Milosevic S, Brookes-Howell L, Harris D, Massey I, Burton J, Stewart P, Samuel K, Jones S, Cox D, Clothier A, Edwards A, Twine CP, Bosanquet DC, Benson R, Birmpili P, Blair R, Bosanquet DC, Dattani N, Dovell G, Forsythe R, Gwilym BL, Hitchman L, Machin M, Nandhra S, Onida S, Preece R, Saratzis A, Shalhoub J, Singh A, Forget P, Gannon M, Celnik A, Duguid M, Campbell A, Duncan K, Renwick B, Moore J, Maresch M, Kamal D, Kabis M, Hatem M, Juszczak M, Dattani N, Travers H, Shalan A, Elsabbagh M, Rocha-Neves J, Pereira-Neves A, Teixeira J, Lyons O, Lim E, Hamdulay K, Makar R, Zaki S, Francis CT, Azer A, Ghatwary-Tantawy T, Elsayed K, Mittapalli D, Melvin R, Barakat H, Taylor J, Veal S, Hamid HKS, Baili E, Kastrisios G, Maltezos C, Maltezos K, Anastasiadou C, Pachi A, Skotsimara A, Saratzis A, Vijaynagar B, Lau S, Velineni R, Bright E, Montague-Johnstone E, Stewart K, King W, Karkos C, Mitka M, Papadimitriou C, Smith G, Chan E, Shalhoub J, Machin M, Agbeko AE, Amoako J, Vijay A, Roditis K, Papaioannou V, Antoniou A, Tsiantoula P, Bessias N, Papas T, Dovell G, Goodchild F, Nandhra S, Rammell J, Dawkins C, Lapolla P, Sapienza P, Brachini G, Mingoli A, Hussey K, Meldrum A, Dearie L, Nair M, Duncan A, Webb B, Klimach S, Hardy T, Guest F, Hopkins L, Contractor U, Clothier A, McBride O, Hallatt M, Forsythe R, Pang D, Tan LE, Altaf N, Wong J, Thurston B, Ash O, Popplewell M, Grewal A, Jones S, Wardle B, Twine C, Ambler G, Condie N, Lam K, Heigberg-Gibbons F, Saha P, Hayes T, Patel S, Black S, Musajee M, Choudhry A, Hammond E, Costanza M, Shaw P, Feghali A, Chawla A, Surowiec S, Encalada RZ, Benson R, Cadwallader C, Clayton P, Van Herzeele I, Geenens M, Vermeir L, Moreels N, Geers S, Jawien A, Arentewicz T, Kontopodis N, Lioudaki S, Tavlas E, Nyktari V, Oberhuber A, Ibrahim A, Neu J, Nierhoff T, Moulakakis K, Kakkos S, Nikolakopoulos K, Papadoulas S, D'Oria M, Lepidi S, Lowry D, Ooi S, Patterson B, Williams S, Elrefaey GH, Gaba KA, Williams GF, Rodriguez DU, Khashram M, Gormley S, Hart O, Suthers E, French S. Short-term risk prediction after major lower limb amputation: PERCEIVE study. Br J Surg 2022; 109:1300-1311. [PMID: 36065602 DOI: 10.1093/bjs/znac309] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 05/06/2022] [Accepted: 07/31/2022] [Indexed: 01/22/2023]
Abstract
BACKGROUND The accuracy with which healthcare professionals (HCPs) and risk prediction tools predict outcomes after major lower limb amputation (MLLA) is uncertain. The aim of this study was to evaluate the accuracy of predicting short-term (30 days after MLLA) mortality, morbidity, and revisional surgery. METHODS The PERCEIVE (PrEdiction of Risk and Communication of outcomE following major lower limb amputation: a collaboratIVE) study was launched on 1 October 2020. It was an international multicentre study, including adults undergoing MLLA for complications of peripheral arterial disease and/or diabetes. Preoperative predictions of 30-day mortality, morbidity, and MLLA revision by surgeons and anaesthetists were recorded. Probabilities from relevant risk prediction tools were calculated. Evaluation of accuracy included measures of discrimination, calibration, and overall performance. RESULTS Some 537 patients were included. HCPs had acceptable discrimination in predicting mortality (931 predictions; C-statistic 0.758) and MLLA revision (565 predictions; C-statistic 0.756), but were poor at predicting morbidity (980 predictions; C-statistic 0.616). They overpredicted the risk of all outcomes. All except three risk prediction tools had worse discrimination than HCPs for predicting mortality (C-statistics 0.789, 0.774, and 0.773); two of these significantly overestimated the risk compared with HCPs. SORT version 2 (the only tool incorporating HCP predictions) demonstrated better calibration and overall performance (Brier score 0.082) than HCPs. Tools predicting morbidity and MLLA revision had poor discrimination (C-statistics 0.520 and 0.679). CONCLUSION Clinicians predicted mortality and MLLA revision well, but predicted morbidity poorly. They overestimated the risk of mortality, morbidity, and MLLA revision. Most short-term risk prediction tools had poorer discrimination or calibration than HCPs. The best method of predicting mortality was a statistical tool that incorporated HCP estimation.
Collapse
Affiliation(s)
- Brenig L Gwilym
- South East Wales Vascular Network, Aneurin Bevan University Health Board, Royal Gwent Hospital, Newport, UK
| | | | | | | | | | | | - Debbie Harris
- Centre for Trials Research, Cardiff University, Cardiff, UK
| | - Ian Massey
- Artificial Limb and Appliance Centre, Rookwood Hospital, Cardiff and Vale University Health Board, Cardiff, UK
| | - Jo Burton
- Artificial Limb and Appliance Centre, Rookwood Hospital, Cardiff and Vale University Health Board, Cardiff, UK
| | - Phillippa Stewart
- Artificial Limb and Appliance Centre, Rookwood Hospital, Cardiff and Vale University Health Board, Cardiff, UK
| | - Katie Samuel
- Department of Anaesthesia, North Bristol NHS Trust, Bristol, UK
| | - Sian Jones
- c/o INVOLVE Health and Care Research Wales, Cardiff, UK
| | - David Cox
- c/o INVOLVE Health and Care Research Wales, Cardiff, UK
| | - Annie Clothier
- South East Wales Vascular Network, Aneurin Bevan University Health Board, Royal Gwent Hospital, Newport, UK
| | - Adrian Edwards
- Division of Population Medicine, Cardiff University, Cardiff, UK
| | - Christopher P Twine
- Bristol, Bath and Weston Vascular Network, North Bristol NHS Trust, Southmead Hospital, Bristol, UK
| | - David C Bosanquet
- South East Wales Vascular Network, Aneurin Bevan University Health Board, Royal Gwent Hospital, Newport, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
McLean D, McBride O, Samardzic T, Sisic M, Dellavalle RP, Tan J. Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial. JAAD Int 2021; 1:190-199. [PMID: 34409339 PMCID: PMC8361909 DOI: 10.1016/j.jdin.2020.09.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/05/2020] [Indexed: 11/29/2022] Open
Abstract
Background Patient decision aids are tools that facilitate shared decision making when clinical evidence and patient values and preferences inform the process. Evidence-based guidelines have been developed for clinicians in hidradenitis suppurativa management. To address treatment decision-making needs of hidradenitis suppurativa patients, we developed a hidradenitis suppurativa patient decision aid. Objective To assess the efficacy of the hidradenitis suppurativa patient decision aid during treatment decision making. Methods An online, participant-blinded, parallel-group, randomized controlled trial of the hidradenitis suppurativa patient decision aid versus Mayo Clinic hidradenitis suppurativa website content (Mayo) was conducted with hidradenitis suppurativa patients. Outcomes were knowledge, decisional conflict, and preparation for decision making. Results Forty participants fulfilled inclusion criteria and were randomized to hidradenitis suppurativa patient decision aid or Mayo. In the hidradenitis suppurativa patient decision aid group, data from 16 and 15 participants were analyzed at phases 1 and 2, respectively. In the Mayo group, data from 15 and 13 participants were analyzed at phases 1 and 2, respectively. Increased knowledge (P < .01) and preparation for decision making (P < .01), as well as reduced decisional conflict (P < .01), were observed in the hidradenitis suppurativa patient decision aid compared with the Mayo group. Limitations The online methodology and recruitment from online hidradenitis suppurativa support groups limits generalizability of findings. Conclusion A hidradenitis suppurativa patient decision aid increased knowledge and preparation for decision making and reduced decisional conflict.
Collapse
Affiliation(s)
- Donna McLean
- Windsor Clinical Research Inc, Windsor, Ontario, Canada
| | | | | | - Mia Sisic
- Windsor Clinical Research Inc, Windsor, Ontario, Canada.,University of Windsor, Windsor, Ontario, Canada
| | - Robert P Dellavalle
- Dermatology Service, Eastern Colorado Health Care System, US Department of Veteran Affairs, Aurora, Colorado.,Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.,Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado
| | - Jerry Tan
- Windsor Clinical Research Inc, Windsor, Ontario, Canada.,University of Windsor, Windsor, Ontario, Canada.,Schulich School of Medicine, Western University, Windsor, Ontario, Canada
| |
Collapse
|
4
|
Atkins E, Kandola S, Kent F, McBride O. Vascular surgery trainee retention in the UK: how many leave and why? A survey of trainee and Training Programme Directors' perceptions. BMC Med Educ 2021; 21:241. [PMID: 33902561 PMCID: PMC8077713 DOI: 10.1186/s12909-021-02668-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/15/2020] [Accepted: 04/14/2021] [Indexed: 06/12/2023]
Abstract
BACKGROUND It is currently not known how many trainees leave vascular surgery, and their reasons for doing so are unclear. This paper is the first to publish the number of UK trainees leaving the training programme and interrogates their reasons for doing so. METHODS An email survey was distributed to current and recent Training Programme Directors (TPDs) to quantify the number of trainees resigning between 2013 and 2019. Trainees resigning a National Training Number (NTN) were surveyed regarding their reasons for doing so. RESULTS Since 2013, 23 UK vascular surgery trainees have resigned NTNs, representing 15.4% of the 149 NTNs awarded between 2013 and our analysis. Reasons for leaving, as relayed by TPDs, included availability of an academic career, geography, health and many other reasons classified as "work-life balance" factors. Data from the trainees surveyed also highlighted work-life balance but also identified pressures within the training system and NHS. CONCLUSIONS UK data of this sort has not previously been available. The authors' primary recommendation is that prospective data collection on trainee retention is carried out, with structured exit interviews with trainees who decide to leave. Our secondary recommendations include improvements to the inter-deanery transfer process and early realistic exposure to vascular surgery for junior doctors to improve trainee retention rates in vascular surgery.
Collapse
Affiliation(s)
- Eleanor Atkins
- Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK.
| | - Sandhir Kandola
- Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK
| | - Frances Kent
- Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
| | | |
Collapse
|
5
|
McBride O, Heslop P, Glover G, Taggart T, Hanna-Trainor L, Shevlin M, Murphy J. Prevalence estimation of intellectual disability using national administrative and household survey data: The importance of survey question specificity. Int J Popul Data Sci 2021; 6:1342. [PMID: 34164584 PMCID: PMC8188522 DOI: 10.23889/ijpds.v6i1.1342] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Background Variability in prevalence estimation of intellectual disability has been attributed to heterogeneity in study settings, methodologies, and intellectual disability case definitions. Among studies based on national household survey data specifically, variability in prevalence estimation has partly been attributed to the level of specificity of the survey questions employed to determine the presence of intellectual disability. Specific aims & method Using standardised difference scoring, and ‘intellectual disability’ survey data from the 2007 Northern Ireland Survey on Activity Limitation and Disability (NISALD) (N=23,689) and the 2011 Northern Ireland Census (N=1,770,217) the following study had two aims. First, we aimed to demonstrate the effects of survey question specificity on intellectual disability prevalence estimation. Second, we aimed to produce reliable estimates of the geographic variation of intellectual disability within private households in Northern Ireland while also assessing the socio-demographic, health-related and disability characteristics of this population. Findings Prevalence estimates generated using the more crudely classified intellectual disability Census data indicated a prevalence of 2% for the overall population, 3.8% for children aged between 0 and 15 years, and 1.5% for citizens aged 16 years or older. Intellectual disability prevalence estimates generated using the more explicitly defined 2007 NISALD data indicated a population prevalence of 0.5% for the overall population, 1.3% for children aged between 0 and 15 years, and 0.3% for citizens aged 16 years or older. The NISALD estimates were consistent with most recent international meta-analysis prevalence estimates. According to the NISALD data, the majority of those with an intellectual disability were male, lived outside Belfast, and experienced severe intellectual disability, with multiple comorbid health conditions. Discussion The current findings highlight the importance of survey question specificity in the estimation of intellectual disability prevalence and provide reliable prevalence estimates of intellectual disability in Northern Ireland. The findings also demonstrate the utility of administrative data for detecting and understanding intellectual disability, and inform recommendations on how to maximise use of future intellectual disability Census data
Collapse
Affiliation(s)
- O McBride
- School of Psychology, Ulster University, Coleraine, Northern Ireland
| | - P Heslop
- School for Policy Studies, University of Bristol, Bristol, United Kingdom
| | - G Glover
- Learning Disability Observatory, Public Health England, London, United Kingdom
| | - T Taggart
- School of Nursing, Ulster University, Derry, Northern Ireland
| | - L Hanna-Trainor
- School of Nursing, Ulster University, Derry, Northern Ireland
| | - M Shevlin
- School of Psychology, Ulster University, Coleraine, Northern Ireland
| | - J Murphy
- School of Psychology, Ulster University, Coleraine, Northern Ireland
| |
Collapse
|
6
|
Tan J, McBride O, McLean D, Samardzic T, Yannuzzi CA, Dellavalle RP, Sayed C, Resnik B, Guilbault S. 18277 Development of a patient decision aid for hidradenitis suppurativa: Facilitating informed shared decision making. J Am Acad Dermatol 2020. [DOI: 10.1016/j.jaad.2020.06.922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
McBride O, McLean D, Samardzic T, Yannuzzi C, Guilbault S, Sayed C, Resnik B, Sisic M, Dellavalle RP, Tan J. Development of a hidradenitis suppurativa patient decision aid. Dermatol Online J 2020; 26:13030/qt18p1n8tt. [PMID: 33342169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 05/09/2020] [Accepted: 07/03/2020] [Indexed: 06/12/2023] Open
Abstract
BACKGROUND Patient decision aids (PDAs) are tools that facilitate informed shared decision-making between patients and health care providers. To address a previously identified need in treatment decision-making in hidradenitis suppurativa (HS), we developed an HS-PDA. METHODS Development of the HS-PDA was based on International Patient Decision Aids Standards. Evidence was derived from the North American Clinical Management Guidelines for HS. RESULTS Content from guidelines was transformed into patient-friendly language and reviewed by three physicians and two patient representatives. Feedback on HS-PDA content, presentation and practicality was obtained from 7 HS patients and 5 physicians. Revisions were made following thematic analysis. All patients felt the content on treatment options contained the right amount of information and 5 found it helpful to see these options contextualized to their values. Each stated they would use the HS-PDA during treatment decision-making. Three and four physicians respectively indicated the content was accurate and language was patient-friendly. LIMITATIONS Small sample sizes may limit generalizability. CONCLUSION This HS-PDA was developed in accordance with international standards based on current HS guidelines with input from patients and physicians. It is available online without cost.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Jerry Tan
- Windsor Clinical Research Inc., Windsor, Ontario University of Windsor, Windsor, Ontario Schulich School of Medicine, Western University, Windsor, Ontario.
| |
Collapse
|
8
|
Hyland P, Shevlin M, McBride O, Murphy J, Karatzias T, Bentall RP, Martinez A, Vallières F. Anxiety and depression in the Republic of Ireland during the COVID-19 pandemic. Acta Psychiatr Scand 2020; 142:249-256. [PMID: 32716520 DOI: 10.1111/acps.13219] [Citation(s) in RCA: 283] [Impact Index Per Article: 70.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/20/2020] [Indexed: 11/26/2022]
Abstract
BACKGROUND The COVID-19 pandemic in Ireland resulted in a nationwide quarantine on March 27, 2020. This study represents the first assessment of rates of anxiety and depression in the general population of Ireland during the pandemic. AIMS Our first aim was to estimate the probable prevalence rates of generalized anxiety disorder (GAD) and depression and to identify sociodemographic risk factors associated with screening positive for GAD or depression. Our second aim was to determine if COVID-19 related anxiety was highest amongst those in society at greatest risk of morality from COVID-19. METHOD Self-report data were collected from a nationally representative Irish sample (N = 1041) online between March 31 and April 5; the first week of the nationwide quarantine measures. Recognized cut-off scores on the GAD-7 and PHQ-9 were used to estimate rates of GAD and depression. Correlates of screening positive for GAD or depression were assessed using logistic regression analysis. RESULTS GAD (20.0%), depression (22.8%) and GAD or depression (27.7%) was common. Screening positive for GAD or depression was associated with younger age, female sex, loss of income due to COVID-19, COVID-19 infection and higher perceived risk of COVID-19 infection. Citizens aged 65 and older had significantly higher levels of COVID-19 related anxiety than adults aged 18-34. CONCLUSIONS Initial results from this multi-wave study monitoring changes in population anxiety and depression throughout the pandemic indicate that GAD and depression were common experiences in the population during the initial phase of the COVID-19 pandemic.
Collapse
Affiliation(s)
- P Hyland
- Department of Psychology, Maynooth University, Kildare, Ireland.,Trinity Centre for Global Health, Trinity College Dublin, Dublin, Ireland
| | - M Shevlin
- School of Psychology, Ulster University, Ulster, UK
| | - O McBride
- School of Psychology, Ulster University, Ulster, UK
| | - J Murphy
- School of Psychology, Ulster University, Ulster, UK
| | - T Karatzias
- School of Health & Social Care, Edinburgh Napier University, Edinburgh, UK
| | | | | | - F Vallières
- Trinity Centre for Global Health, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
9
|
Dattani N, Shalhoub J, Nandhra S, Lane T, Abu-Own A, Elbasty A, Jones A, Duncan A, Garnham A, Thapar A, Murray A, Baig A, Saratzis A, Sharif A, Huasen B, Dawkins C, Nesbitt C, Carradice D, Morrow D, Bosanquet D, Kavanagh E, Shaikh F, Gosi G, Ambler G, Fulton G, Singh G, Travers H, Moore H, Olivier J, Hitchman L, O’Donohoe M, Popplewell M, Medani M, Jenkins M, Goh MA, Lyons O, McBride O, Moxey P, Stather P, Burns P, Forsythe R, Sam R, Brar R, Brightwell R, Benson R, Onida S, Paravastu S, Lambracos S, Vallabhaneni SR, Walsh S, Aktar T, Moloney T, Mzimba Z, Nyamekye I. Reducing the risk of venous thromboembolism following superficial endovenous treatment: A UK and Republic of Ireland consensus study. Phlebology 2020; 35:706-714. [DOI: 10.1177/0268355520936420] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Objectives Venous thromboembolism is a potentially fatal complication of superficial endovenous treatment. Proper risk assessment and thromboprophylaxis could mitigate this hazard; however, there are currently no evidence-based or consensus guidelines. This study surveyed UK and Republic of Ireland vascular consultants to determine areas of consensus. Methods A 32-item survey was sent to vascular consultants via the Vascular and Endovascular Research Network (phase 1). These results generated 10 consensus statements which were redistributed (phase 2). ‘Good’ and ‘very good’ consensus were defined as endorsement/rejection of statements by >67% and >85% of respondents, respectively. Results Forty-two consultants completed phase 1. This generated seven statements regarding risk factors mandating peri-procedural pharmacoprophylaxis and three statements regarding specific pharmacoprophylaxis regimes. Forty-seven consultants completed phase 2. Regarding venous thromboembolism risk factors mandating pharmacoprophylaxis, ‘good’ and ‘very good’ consensus was achieved for 5/7 and 2/7 statements, respectively. Regarding specific regimens, ‘very good’ consensus was achieved for 3/3 statements. Conclusions The main findings from this study were that there was ‘good’ or ‘very good’ consensus that patients with any of the seven surveyed risk factors should be given pharmacoprophylaxis with low-molecular-weight heparin. High-risk patients should receive one to two weeks of pharmacoprophylaxis rather than a single dose.
Collapse
Affiliation(s)
- Nikesh Dattani
- Worcestershire Acute Hospitals NHS Trust, The Vascular Surgery Unit, Worcester, Worcestershire, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Joseph Shalhoub
- Imperial College Healthcare NHS Trust, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Sandip Nandhra
- Northern Vascular Centre, Freeman Hospital, Newcastle University, Newcastle Upon Tyne, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Tristan Lane
- Department of Surgery and Cancer, Imperial College London, Academic Section of Vascular Surgery, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Abdulsalam Abu-Own
- Colchester Hospital University NHS Foundation Trust, Colchester, Essex, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Ahmed Elbasty
- Frimley Park Hospital NHS Foundation Trust, Frimley, Surrey, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Aled Jones
- Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Andrew Duncan
- University Hospitals of Leicester NHS Trust, Leicester, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Andrew Garnham
- Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Ankur Thapar
- Imperial College London, Academic Section of Vascular Surgery, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Anna Murray
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Anzar Baig
- Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Athanasios Saratzis
- University Hospitals of Leicester NHS Trust, Leicester, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Atif Sharif
- Dudley Group NHS Foundation Trust, Dudley, West Midlands, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Bella Huasen
- Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Claire Dawkins
- Sunderland Royal Hospital, Sunderland, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Craig Nesbitt
- Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Daniel Carradice
- Hull Royal Infirmary, Hull, Kingston upon Hull, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Darren Morrow
- Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - David Bosanquet
- Southmead Hospital, Bristol, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Eamon Kavanagh
- University of Limerick Hospitals Group, Vascular Surgery, Limerick, Ireland
- University of Limerick Graduate Entry Medical School, Limerick, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Faisal Shaikh
- Heartlands Hospital, Birmingham, West Midlands, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Gergely Gosi
- University Hospital Waterford, Vascular Surgery, Waterford, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Graeme Ambler
- Royal Gwent Hospital, Newport, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Gregory Fulton
- Cork University Hospital Group, Cork, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Gurdas Singh
- Guy’s Hospital, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Hannah Travers
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Hayley Moore
- Frimley Park Hospital NHS Foundation Trust, Frimley, Surrey, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - James Olivier
- Musgrove Park Hospital, Taunton, Somerset, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Louise Hitchman
- Hull Royal Infirmary, Hull, Kingston upon Hull, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Martin O’Donohoe
- Mater Misericordiae University Hospital, Dublin, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Matthew Popplewell
- University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Mekki Medani
- Beaumont Hospital, Dublin, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Michael Jenkins
- Imperial College Healthcare NHS Trust, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Mingzheng A Goh
- Basildon University Hospital, Basildon, Essex, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Oliver Lyons
- Basildon University Hospital, Basildon, Essex, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Olivia McBride
- Edinburgh Royal Infirmary, Edinburgh, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Paul Moxey
- St George’s Hospital, Vascular Surgery, London, Tooting, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Philip Stather
- Addenbrooke’s Hospital, Cambridge, Cambridgeshire, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Phillipa Burns
- Edinburgh Royal Infirmary, Edinburgh, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Rachel Forsythe
- Royal Infirmary of Edinburgh, Edinburgh, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Rachel Sam
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Ranjeet Brar
- Royal Free London NHS Foundation Trust, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Robert Brightwell
- Norfolk and Norwich University Hospital NHS Trust, Norwich, Norfolk, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Ruth Benson
- University of Birmingham Institute of Cancer and Genomic Sciences, Birmingham, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Sarah Onida
- Imperial College London, Academic Section of Vascular Surgery, London, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Sharath Paravastu
- Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, Gloucestershire, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Simon Lambracos
- Western Sussex Hospitals NHS Trust, Worthing, West Sussex, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Srinivasa R Vallabhaneni
- Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Stewart Walsh
- Lambe Institute for Translational Discipline of Surgery, National University of Ireland, Galway, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Tasleem Aktar
- Dudley Group NHS Foundation Trust, Dudley, West Midlands, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Tony Moloney
- University of Limerick Hospitals Group, Dooradoyle, Limerick, Ireland
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Zola Mzimba
- Altnagelvin Hospitals Health and Social Services Trust, Londonderry, UK
- *The Vascular and Endovascular Research Network (VERN) collaborators
| | - Isaac Nyamekye
- Worcestershire Acute Hospitals NHS Trust, The Vascular Surgery Unit, Worcester, Worcestershire, UK
| |
Collapse
|
10
|
McBride O, McLean D, Samardzic T, Yannuzzi C, Guilbault S, Sayed C, Resnik B, Sisic M, Dellavalle RP, Tan J. Development of a hidradenitis suppurativa patient decision aid. Dermatol Online J 2020. [DOI: 10.5070/d32611047214] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
11
|
McBride O, Schneider E, Das B, Sastre L. In Person, Online or Social Media? Preferences of Low-Income Patients for Nutrition and Physical Activity Programming within Community Clinics. J Acad Nutr Diet 2019. [DOI: 10.1016/j.jand.2019.08.156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Mordi I, Forsythe R, Bown M, Lang CC, Newby D, Gellatly C, Chin C, McBride O, Saratzis A, Iskandar Z, Chalmers R, Huang J, Choy A. P6040The novel biomarker plasma desmosine, a marker of elastin breakdown, is an independent predictor of abdominal aortic aneurysm events independent of aneurysm size. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- I Mordi
- University of Dundee, Dundee, United Kingdom
| | - R Forsythe
- University of Edinburgh, Edinburgh, United Kingdom
| | - M Bown
- University of Leicester, Leicester, United Kingdom
| | - C C Lang
- University of Dundee, Dundee, United Kingdom
| | - D Newby
- University of Edinburgh, Edinburgh, United Kingdom
| | - C Gellatly
- University of Leicester, Leicester, United Kingdom
| | - C Chin
- National University Heart Centre, Singapore, Singapore
| | - O McBride
- University of Edinburgh, Edinburgh, United Kingdom
| | - A Saratzis
- University of Leicester, Leicester, United Kingdom
| | - Z Iskandar
- Ninewells Hospital, Dundee, United Kingdom
| | - R Chalmers
- University of Edinburgh, Edinburgh, United Kingdom
| | - J Huang
- University of Dundee, Dundee, United Kingdom
| | - A Choy
- University of Dundee, Dundee, United Kingdom
| |
Collapse
|
13
|
Hiremath S, Kayibanda JF, Chow BJW, Fergusson D, Knoll GA, Shabana W, Lahey B, McBride O, Davis A, Akbari A. Drug discontinuation before contrast procedures and the effect on acute kidney injury and other clinical outcomes: a systematic review protocol. Syst Rev 2018; 7:34. [PMID: 29467030 PMCID: PMC5822653 DOI: 10.1186/s13643-018-0701-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2017] [Accepted: 02/15/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Contrast-induced acute kidney injury (CI-AKI) is defined as worsening of renal function after the administration of iodinated contrast material. In patients with cardiovascular disease, kidney disease, and/or diabetes, renin-angiotensin system blockers, non-steroidal anti-inflammatory drugs, diuretics, and metformin can increase the risk of CI-AKI when undergoing contrast imaging. Despite CI-AKI being the leading iatrogenic cause of acute kidney injury, there is a lack of sufficient scientific evidence supporting which drugs should be stopped, when they should be stopped, and when they should be resumed. The purpose of this systematic review is to assess (1) the effect of withholding medication before contrast procedures on the risk of CI-AKI and other clinical outcomes and (2) the incidence of adverse events occurring after withholding these drugs prior to contrast procedures. This protocol has been registered with PROSPERO, https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016033178 . METHODS An information specialist will assist in searching MEDLINE, Embase, and the Cochrane Library databases to identify randomized controlled trials, observational studies, case reports, and case series. Relevant abstracts from professional society meetings and web-based registries of clinical trials will also be included. Studies included will compare patients aged ≥ 18 years instructed to continue taking the drugs of interest and those advised to stop taking them before undergoing contrast procedures. If these drugs are not withheld prior to contrast procedures, the studies must compare patients who are administered these drugs and those who are not before undergoing contrast procedures. Two reviewers will independently screen the titles and abstracts of the studies obtained from the search using pre-defined inclusion criteria and will then extract data from the full texts of selected studies. The quality of the studies will be assessed by two independent reviewers using the Cochrane Risk of Bias 2.0 tool for randomized trials and the Newcastle-Ottawa Scale for observational studies. DISCUSSION This systematic review will provide a synthesis of current evidence on the discontinuation of drugs prior to contrast procedures and its effect on CI-AKI and other clinical outcomes. These findings will provide clinicians with guidelines and serve as a strong research base for future studies in this field. SYSTEMATIC REVIEW REGISTRATION PROSPERO CRD42016033178.
Collapse
Affiliation(s)
- Swapnil Hiremath
- The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | | | - Benjamin J. W. Chow
- University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, ON K1Y 4W7 Canada
| | - Dean Fergusson
- Ottawa Hospital Research Institute, Centre for Practice Changing Research, 1053 Carling Ave, Ottawa, ON K1Y 4E9 Canada
| | - Greg A. Knoll
- The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | - Wael Shabana
- The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | - Brianna Lahey
- Kidney Research Centre, The Ottawa Hospital, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | - Olivia McBride
- Kidney Research Centre, The Ottawa Hospital, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | - Alexandra Davis
- The Ottawa Hospital, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| | - Ayub Akbari
- The Ottawa Hospital and the University of Ottawa, 1967 Riverside Drive, Ottawa, ON K1H7W9 Canada
| |
Collapse
|
14
|
Abstract
BACKGROUND Deep venous thrombosis (DVT) occurs in approximately one in 1000 adults every year, and has an annual mortality of 14.6%. In particular, iliofemoral DVT can lead to recurrent thrombosis and post-thrombotic syndrome (PTS), a painful condition which can lead to chronic venous insufficiency, oedema, and ulceration. It causes significant disability, impaired quality of life, and economic burden. Early thrombus removal techniques have been advocated in patients with an iliofemoral DVT in order to improve vein patency, prevent valvular dysfunction, and reduce future complications, such as post-thrombotic syndrome and venous ulceration. One such technique is pharmacomechanical thrombectomy, a combination of catheter-based thrombectomy and catheter-directed thrombolysis. OBJECTIVES To assess the effects of pharmacomechanical thrombectomy versus anticoagulation (alone or with compression stockings), mechanical thrombectomy, thrombolysis, or other endovascular techniques in the management of people with acute DVT of the iliofemoral vein. SEARCH METHODS The Cochrane Vascular Information Specialist searched the Specialised Register (last searched December 2015) and the Cochrane Register of Studies (last searched December 2015). We searched clinical trials databases for details of ongoing or unpublished studies and the reference lists of relevant articles retrieved by electronic searches for additional citations. SELECTION CRITERIA Randomised controlled trials in which patients with an iliofemoral deep vein thrombosis were allocated to receive pharmacomechanical thrombectomy versus anticoagulation, mechanical thrombectomy, thrombolysis (systemic or catheter directed thrombolysis), or other endovascular techniques for the treatment of iliofemoral DVT. DATA COLLECTION AND ANALYSIS At least two review authors independently assessed studies identified for potential inclusion. MAIN RESULTS We found no randomised controlled trials that met the eligibility criteria for this review. We identified one ongoing study. AUTHORS' CONCLUSIONS There were no randomised controlled trials that assessed the effects of pharmacomechanical thrombectomy versus anticoagulation (alone or with compression stockings), mechanical thrombectomy, thrombolysis, or other endovascular techniques in the management of people with acute DVT of the iliofemoral vein that met the eligibility criteria for this review. Further high quality randomised controlled trials are needed.
Collapse
Affiliation(s)
- Lindsay Robertson
- Freeman HospitalDepartment of Vascular SurgeryNewcastle upon Tyne Hospitals NHS Foundation TrustHigh HeatonNewcastle upon TyneUKNE7 7DN
| | - Olivia McBride
- Royal Infirmary of EdinburghDepartment of Vascular SurgeryEdinburghUK
| | - Anne Burdess
- Royal Infirmary of EdinburghDepartment of Vascular SurgeryEdinburghUK
| | | |
Collapse
|
15
|
|
16
|
Weich S, Bebbington P, Rai D, Stranges S, McBride O, Spiers N, Meltzer H, Brugha T. The population impact of common mental disorders and long-term physical conditions on disability and hospital admission. Psychol Med 2013; 43:921-931. [PMID: 22909411 DOI: 10.1017/s0033291712001705] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND Long-term physical conditions (LTCs) consume the largest share of healthcare budgets. Although common mental disorders (CMDs) and LTCs often co-occur, the potential impact of improved mental health treatment on severe disability and hospital admissions for physical health problems remains unknown. Method A cross-sectional study of 7403 adults aged 16-95 years living in private households in England was performed. LTCs were ascertained by prompted self-report. CMDs were ascertained by structured clinical interview. Disability was assessed using questions about problems with activities of daily living. Population impact and potential preventive gain were estimated using population-attributable fraction (PAF), and conservative estimates were obtained using 'treated non-cases' as the reference group. RESULTS Of the respondents, 20.7% reported at least one LTC. The prevalence of CMDs increased with the number of LTCs, but over two-thirds (71.2%) of CMD cases in people with LTCs were untreated. Statistically significant PAFs were found for CMDs and recent hospital admission [13.5%, 95% confidence intervals (CI) 6.6-20.0] and severe disability (31.3%, 95% CI 27.1-35.2) after adjusting for LTCs and other confounders. Only the latter remained significant when using the most conservative estimate of PAF (21.8%, 95% CI 14.0-28.9), and this was reduced only slightly when considering only participants with LTCs (18.5%, 95% CI 7.9-27.9). CONCLUSIONS Better treatments for CMDs in people with LTCs could achieve almost the same population health gain in terms of reducing severe disability as those targeted at the entire population. Interventions to reduce the prevalence of CMDs among people with LTCs should be part of routine medical care.
Collapse
Affiliation(s)
- S Weich
- Division of Mental Health and Wellbeing, Warwick Medical School, University of Warwick, Coventry, UK.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Doyle F, Watson R, Morgan K, McBride O. A hierarchy of distress and invariant item ordering in the General Health Questionnaire-12. J Affect Disord 2012; 139:85-8. [PMID: 22421030 DOI: 10.1016/j.jad.2011.10.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/02/2011] [Revised: 10/14/2011] [Accepted: 10/14/2011] [Indexed: 10/28/2022]
Abstract
BACKGROUND Invariant item ordering (IIO) is defined as the extent to which items have the same ordering (in terms of item difficulty/severity - i.e. demonstrating whether items are difficult [rare] or less difficult [common]) for each respondent who completes a scale. IIO is therefore crucial for establishing a scale hierarchy that is replicable across samples, but no research has demonstrated IIO in scales of psychological distress. We aimed to determine if a hierarchy of distress with IIO exists in a large general population sample who completed a scale measuring distress. METHODS Data from 4107 participants who completed the 12-item General Health Questionnaire (GHQ-12) from the Northern Ireland Health and Social Wellbeing Survey 2005-6 were analysed. Mokken scaling was used to determine the dimensionality and hierarchy of the GHQ-12, and items were investigated for IIO. RESULTS All items of the GHQ-12 formed a single, strong unidimensional scale (H=0.58). IIO was found for six of the 12 items (H-trans=0.55), and these symptoms reflected the following hierarchy: anhedonia, concentration, participation, coping, decision-making and worthlessness. LIMITATIONS The cross-sectional analysis needs replication. CONCLUSIONS The GHQ-12 showed a hierarchy of distress, but IIO is only demonstrated for six of the items, and the scale could therefore be shortened. Adopting brief, hierarchical scales with IIO may be beneficial in both clinical and research contexts.
Collapse
Affiliation(s)
- F Doyle
- Division of Population Health Sciences (Psychology), Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland.
| | | | | | | |
Collapse
|
18
|
Weich S, McBride O, Hussey D, Exeter D, Brugha T, McManus S. Latent class analysis of co-morbidity in the Adult Psychiatric Morbidity Survey in England 2007: implications for DSM-5 and ICD-11. Psychol Med 2011; 41:2201-2212. [PMID: 21375797 DOI: 10.1017/s0033291711000249] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
BACKGROUND Psychiatric co-morbidity is complex and ubiquitous. Our aim was to describe the extent, nature and patterning of psychiatric co-morbidity within a representative sample of the adult population of England, using latent class analysis. METHOD Data were used from the 2007 Adult Psychiatric Morbidity Survey, a two-phase national household survey undertaken in 2007 comprising 7325 participants aged 16 years and older living in private households in England. The presence of 15 common mental health and behavioural problems was ascertained using standardized clinical and validated self-report measures, including three anxiety disorders, depressive episode, mixed anxiety depressive disorder, psychosis, antisocial and borderline personality disorders, eating disorders, post-traumatic stress disorder, attention deficit disorder, alcohol and drug dependencies, problem gambling and attempted suicide. RESULTS A four-class model provided the most parsimonious and informative explanation of the data. Most participants (81.6%) were assigned to a non-symptomatic or 'Unaffected' class. The remainder were classified into three qualitatively different symptomatic classes: 'Co-thymia' (12.4%), 'Highly Co-morbid' (5.0%) and 'Addictions' (1.0%). Classes differed in mean numbers of conditions and impairments in social functioning, and these dimensions were correlated. CONCLUSIONS Our findings confirm that mental disorders typically co-occur and are concentrated in a relatively small number of individuals. Conditions associated with the highest levels of disability, mortality and cost--psychosis, suicidality and personality disorders--are often co-morbid with more common conditions. This needs to be recognized when planning services and when considering aetiology.
Collapse
Affiliation(s)
- S Weich
- Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.
| | | | | | | | | | | |
Collapse
|
19
|
|
20
|
McBride O, Adamson G, Bunting BP, McCann S. Assessing the General Health of Diagnostic Orphans Using the Short Form Health Survey (SF-12v2): A Latent Variable Modelling Approach. Alcohol Alcohol 2008; 44:67-76. [DOI: 10.1093/alcalc/agn083] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
21
|
McBride O, Athwal RS. Chromosome-mediated gene transfer with resultant expression and integration of the transferred genes in eukaryotic cells. Brookhaven Symp Biol 1977:116-26. [PMID: 113051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|